Top Page
Diatreme Resources Limited
(Sydney:DRX)
Diatreme Resources Limited (DRX) vs. iShares MSCI Australia ETF (EWA)
Diatreme Resources Limited Business Overview & Revenue Model
Diatreme Resources Limited Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 886.46K | 468.51K | 110.14K | 23.94K | 21.28K | Gross Profit |
| 886.46K | 254.29K | -61.14K | -77.02K | -50.22K | EBIT |
| -1.22M | -3.34M | -3.29M | -2.05M | -1.45M | EBITDA |
| -4.61M | 10.70M | -2.94M | -1.94M | -795.89K | Net Income Common Stockholders |
| -439.53K | 10.37M | 4.98M | -2.15M | -1.04M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 5.19M | 10.77M | 13.64M | 6.50M | 5.79M | Total Assets |
| 95.45M | 66.53M | 55.33M | 33.14M | 25.62M | Total Debt |
| 1.20M | 1.75M | 1.54M | 1.61M | 1.64M | Net Debt |
| -3.98M | -9.03M | -12.10M | -4.89M | -4.15M | Total Liabilities |
| 2.51M | 2.96M | 2.59M | 2.37M | 2.40M | Stockholders Equity |
| 92.94M | 63.57M | 52.75M | 30.76M | 23.22M |
| Cash Flow | Free Cash Flow | |||
| -7.71M | -2.80M | -9.57M | -8.70M | -4.24M | Operating Cash Flow |
| -6.00M | -2.32M | -2.51M | -2.15M | -1.14M | Investing Cash Flow |
| 1.06M | -462.49K | -6.95M | -6.57M | -2.33M | Financing Cash Flow |
| -643.79K | -86.47K | 16.60M | 9.43M | 6.77M |
Diatreme Resources Limited Technical Analysis
Diatreme Resources Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
57 Neutral | $7.04B | 3.12 | -3.45% | 5.79% | 0.62% | -50.55% | |
41 Neutral | AU$100.17M | 6.07 | -0.45% | ― | ― | -103.57% | |
| $118.77M | ― | -17.81% | ― | ― | ― | ||
| $1.08B | 6.82 | 10.39% | 2.12% | ― | ― | ||
| $43.05M | ― | -36.70% | ― | ― | ― | ||
| €14.54M | ― | ― | ― | ― | |||
42 Neutral | AU$30.02M | ― | -139.33% | ― | 65.38% | -46.00% |
Diatreme Resources Limited Corporate Events
Diatreme Resources Limited has strengthened its position as Australia’s leading silica sands miner through the successful acquisition of Metallica Minerals Limited, expanding its resource base to 463 million tonnes. The company is advancing its Northern Silica Project with regulatory approvals and has secured international partnerships, positioning itself to meet the growing demand from the global solar industry.
Diatreme Resources announced the sale of a dormant intellectual property asset related to scandium extraction, generating $562,500 to support its silica sand project development. Despite reporting a net loss of $439,527 for the fiscal year, the company highlighted a significant expansion of its silica sand resources. As of March 31, 2025, Diatreme’s cash and liquid assets totaled $4.2 million, with an additional $13.7 million in joint ventures, totaling $17.9 million.
Diatreme Resources Limited has released its corporate governance statement for the financial year ending December 31, 2024, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles, highlighting their commitment to transparency and accountability. This move is expected to bolster stakeholder confidence and reinforce Diatreme’s reputation in the industry by demonstrating their compliance with governance standards.
Diatreme Resources Limited has released its Annual Report for 2024, highlighting key achievements and financial performance. The report includes comprehensive details on the company’s environmental, social, and governance initiatives, as well as its financial statements, which indicate a strategic focus on sustainable growth and stakeholder engagement.
Diatreme Resources Limited has announced its Annual General Meeting (AGM) scheduled for May 22, 2025, in Brisbane. The meeting will cover the company’s financial statements, directors’ and auditors’ reports for the year ending December 31, 2024. Shareholders are encouraged to participate by submitting proxy forms by May 20, 2025. The agenda includes a non-binding resolution on the remuneration report, which will be advisory and not binding on the company or its directors.
Diatreme Resources Limited announced the sale of intellectual property related to scandium extraction technology by its subsidiary, Touchstone Resources Pty Ltd, for $562,500. The proceeds will bolster the company’s cash reserves, supporting the advancement of its Northern Silica Project in North Queensland, thereby strengthening its financial position to achieve its development goals.
Diatreme Resources Limited has announced a change in the interests of a substantial holder, Sibelco Asia Pacific Pty Ltd. The voting power of Sibelco Asia Pacific Pty Ltd in Diatreme Resources Limited has increased from 22.01% to 23.05%, reflecting an acquisition of additional fully paid ordinary shares. This change in voting power may influence the company’s strategic decisions and impact its market dynamics.
Diatreme Resources Limited has successfully completed its 2024 drilling program at the Northern Silica Project, marking a significant milestone in its development of high-purity silica for the photovoltaic glass market. The results, which include a substantial mineral resource upgrade potential, indicate a promising future for the project, supporting further feasibility studies and commercial discussions. This progress is expected to contribute to Queensland’s critical minerals industry, providing new jobs and investments in the region.